Aug 30, 2022
Aktis Oncology Raises USD 84 Million To Advance Novel Targeted Alpha Radiopharmaceuticals Aktis Oncology has raised an additional USD 84 million in its Series A round, adding to the USD 72 million raised last year to help bring its radiopharmaceuticals to market. The extension to the first round included Merck's...
Read More...
Aug 04, 2022
iRhythm receives FDA clearance for ZEUS System for Zio watch iRhythm Technologies, a leading digital healthcare solutions firm focused on advancing cardiac care, announced that it received FDA 510(k) clearance for the ZEUS (Zio ECG Utilization Software) System for the Zio Watch. It is produced in partnership wit...
Read More...
Apr 15, 2022
Glaucoma is a group of progressive optic neuropathy which is characterized by the degradation of ganglion cells present in the retina. The loss of the retinal ganglion is associated with intraocular pressure (IOP), an elevated IOP due to an imbalance in the production and drainage of aqueous humor that might lead t...
Read More...
Jan 13, 2022
Leman Micro Devices tested against the cuffed blood measurement devices reported positive results On January 07, 2022, the e-Checkup system by Leman Micro Devices tested in the world’s first clinical trial against the cuffed blood measurement devices reported positive results. The e-Checkup and its sma...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper